Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits
- 28 November 2020
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 316, 32-40
- https://doi.org/10.1016/j.atherosclerosis.2020.11.028
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 48 references indexed in Scilit:
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation studyThe Lancet, 2012
- Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemiaJournal of Lipid Research, 2012
- Proteomic Characterization of Human Plasma High Density Lipoprotein Fractionated by Gel Filtration ChromatographyJournal of Proteome Research, 2010
- Expression of Human ApoAII in Transgenic Rabbits Leads to DyslipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteinsJournal of Lipid Research, 2009
- Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDLJCI Insight, 2007
- Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosisLaboratory Investigation, 2004
- Plasma Kinetics of Cholesteryl Ester Transfer Protein in the RabbitArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- The rabbit as an animal model of hepatic lipase deficiencyBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Effect of disulfide cleavage on the molecular weight of one of the major polypeptides of human serum high density lipoproteinFEBS Letters, 1971